Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiko Oshima

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Ryoikibetsu Shokogun Shirizu|July 25, 2003
[Anxiolytics]Saori Yamashita, Ikuo Kudo, Akihiko Oshima, et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|September 19, 2003
[Treatment algorithms for mood disorders]Akihiko Oshima, Kazuyuki Nakagome, Keiji Okimoto, et al.
Psychoneuroendocrinology|December 11, 2007
Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depressionToshimi Owashi, Tempei Otsubo, Akihiko Oshima, et al.
Journal of Psychiatric Research|April 7, 2007
Relationships of DEX/CRH and GHRH test results to the outcome of depression--preliminary results suggest the GHRH test may predict relapse after dischargeToshimi Owashi, Tempei Otsubo, Akihiko Oshima, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 14, 2003
Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775Akihiko Oshima, Cornelia Flachskamm, Johannes M H M Reul, et al.
Pharmacology, Biochemistry, and Behavior|May 15, 2007
Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of ratsHiroomi Moro, Hirohito Sato, Itsurou Ida, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|December 12, 2007
Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorderTsutomu Sakai, Akihiko Oshima, Yusuke Nozaki, et al.
Journal of Neurochemistry|May 21, 2008
Large-scale analysis of glucocorticoid target genes in rat hypothalamusHirohito Sato, Yukio Horikawa, Katsumi Iizuka, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|January 24, 2008
[Organic cause of emotional depression]Masahiko Mikuni, Masato Fukuda, Akihiko Oshima, et al.
Psychiatry Research|June 26, 2007
HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regionsMasako Aihara, Itsuro Ida, Naoya Yuuki, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Ryoikibetsu Shokogun Shirizu|July 25, 2003
[Anxiolytics]Saori Yamashita, Ikuo Kudo, Akihiko Oshima, et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|September 19, 2003
[Treatment algorithms for mood disorders]Akihiko Oshima, Kazuyuki Nakagome, Keiji Okimoto, et al.
Psychoneuroendocrinology|December 11, 2007
Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depressionToshimi Owashi, Tempei Otsubo, Akihiko Oshima, et al.
Journal of Psychiatric Research|April 7, 2007
Relationships of DEX/CRH and GHRH test results to the outcome of depression--preliminary results suggest the GHRH test may predict relapse after dischargeToshimi Owashi, Tempei Otsubo, Akihiko Oshima, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 14, 2003
Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775Akihiko Oshima, Cornelia Flachskamm, Johannes M H M Reul, et al.
Pharmacology, Biochemistry, and Behavior|May 15, 2007
Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of ratsHiroomi Moro, Hirohito Sato, Itsurou Ida, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|December 12, 2007
Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorderTsutomu Sakai, Akihiko Oshima, Yusuke Nozaki, et al.
Journal of Neurochemistry|May 21, 2008
Large-scale analysis of glucocorticoid target genes in rat hypothalamusHirohito Sato, Yukio Horikawa, Katsumi Iizuka, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|January 24, 2008
[Organic cause of emotional depression]Masahiko Mikuni, Masato Fukuda, Akihiko Oshima, et al.
Psychiatry Research|June 26, 2007
HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regionsMasako Aihara, Itsuro Ida, Naoya Yuuki, et al.
Pageof 2